Parexel International Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 0.40 M
as on 18-07-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 6.25%
(FY 2023)
- Profit -36.01%
(FY 2023)
- Ebitda 41.19%
(FY 2023)
- Net Worth 9.43%
(FY 2023)
- Total Assets 30.34%
(FY 2023)
About Parexel International Clinical Research
The Corporate was formerly known as Parexel International Synchron Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Michael Iii, Sanjay Vyas, and Paul Armstrong serve as directors at the Company.
- CIN/LLPIN
U74220KA2006PTC039077
- Company No.
039077
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bengaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Parexel International Clinical Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Vyas  | Director | 27-Jun-2019 | Current |
| Paul Armstrong | Director | 10-Aug-2020 | Current |
| Michael Iii | Director | 20-Dec-2017 | Current |
Financial Performance of Parexel International Clinical Research.
Parexel International Clinical Research Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.25% increase. The company also saw a substantial fall in profitability, with a 36.01% decrease in profit. The company's net worth moved up by a moderate rise of 9.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parexel International Clinical Research?
In 2023, Parexel International Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Parexel International India Safety Services Private LimitedActive 20 years 7 monthsMichael Iii, Sanjay Vyas and 1 more are mutual person
Parexel International (India) Private LimitedActive 18 years 1 monthMichael Iii, Sanjay Vyas and 1 more are mutual person
Parexel International Services India Private LimitedActive 10 yearsMichael Iii, Sanjay Vyas and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parexel International Clinical Research?
Parexel International Clinical Research has a workforce of 74 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parexel International Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parexel International Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
